What would an antiviral pill mean for the fight against Covid-19?

Merck and Ridgeback Biotherapeutics announced on Friday early result that indicate their experimental oral antiviral drug molnupiravir might halve the risk of death or hospitalization from Covid-19.

Related Keywords

Canada ,United Kingdom ,White House ,District Of Columbia ,United States ,Daria Hazuda ,Mark Denison ,Jeff Zients ,Leana Wen ,Scott Gottlieb ,Eli Lilly ,Ridgeback Biotherapeutics ,Myron Cohen ,Glaxosmithkline ,Vanderbilt Institute For Infection ,Gilead Sciences ,Science Media Center ,Warnermedia Company ,World Health Organization ,Drug Administration ,University Of North Carolina ,National Institutes Of Health Covid ,Baltimore City Health ,Cnn ,Agriculture Organization Of The United Nations ,Cable News Network Inc ,National Institutes ,Vanderbilt Institute ,Baltimore City Health Commissioner ,Coordinator Jeff Zients ,News Network ,Agriculture Organization ,United Nations ,Iology ,Biotechnology ,Usiness And Industry Sectors ,Business ,Conomy And Trade ,Coronavirus ,Iseases And Disorders ,Ealth And Medical ,Health Care ,Infectious Diseases ,Ife Forms ,Medical Biotechnology ,Icroscopic Life ,Pharmaceutical Industry ,Pharmaceuticals ,Harmaceuticals And Prescription Drugs ,Respiratory Diseases ,Science ,Viruses ,Mmunology ,Edical Fields And Specialties ,Companies ,Ontinents And Regions ,Gilead Sciences Inc ,Overnment Organizations Us ,Edical Treatments And Procedures ,Merck ,North America ,He Americas ,S Department Of Health And Human Services ,S Federal Departments And Agencies ,Us Food And Drug Administration ,Ommunicable Disease Control ,Public Health ,Accination And Immunization ,